Enzymology of tirapazamine metabolism: A review

A. V. Patterson, M. P. Saunders, E. C. Chinje, L. H. Patterson, I. J. Stratford

    Research output: Chapter in Book/Conference proceedingChapter

    Abstract

    The enzymology of tirapazamine (TPZ, SR 4233, WIN 59075, 3-amino-1,2,4-benzotriazene 1,4-dioxide, Tirazone®) has been extensively studied in rodents and to a lesser extent in human systems. While it is clear that the initial reductive step in TPZ activation is enzyme-mediated, there is limited consensus in the published literature as to the relative contributions of the cellular reductases involved. Moreover, not only is the importance of subcellullar localization for these putative activating reductase(s) far from clear, but their activity profiles in vivo are poorly defined. The same might also be said of the potential detoxifying enzymes. This review will attempt to establish what common ground exists regarding the enzymology of TPZ metabolism, and will relate the available evidence to the enzyme profiles found in human cell lines in vitro, as well as in xenograft models and human solid rumours.
    Original languageEnglish
    Title of host publicationAnti-Cancer Drug Design|Anti-Cancer Drug Des.
    PublisherOxford University Press
    Pages541-573
    Number of pages32
    Volume13
    Publication statusPublished - 1998

    Keywords

    • Cytotoxicity
    • Enzymology
    • Free radical
    • Hypoxia
    • One-electron bioactivation
    • Tirapazamine

    Fingerprint

    Dive into the research topics of 'Enzymology of tirapazamine metabolism: A review'. Together they form a unique fingerprint.

    Cite this